XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - 3 months ended Mar. 31, 2024 - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Capital Surplus
Retained Earnings
Accumulated Other Comprehensive Loss
Unvested Restricted Stock
Vested Restricted Stock Units
Beginning balance (in shares) at Dec. 31, 2023   0 8,841,349          
Beginning balance at Dec. 31, 2023 $ 214,964 $ 0 $ 44,479 $ 78,361 $ 102,523 $ (8,379) $ (466) $ (1,554)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net Income 8,119       8,119      
Issuance of common stock (in shares)     1,237          
Issuance of common stock 31   $ 6 25        
Exercise of common stock options (in shares)     25,771          
Exercise of common stock options 354   $ 129 225        
Issuance of restricted stock (in shares)     26,812          
Issuance of restricted stock 0   $ 134 574     (708)  
Forfeiture of restricted stock (in shares)     (375)          
Forfeiture of restricted stock 0   $ (2) (6)     8  
Stock-based compensation 239     103     136  
Common stock dividends (804)       (804)      
Other comprehensive loss (22)         (22)    
Ending balance (in shares) at Mar. 31, 2024   0 8,894,794          
Ending balance at Mar. 31, 2024 $ 222,881 $ 0 $ 44,746 $ 79,282 $ 109,838 $ (8,401) $ (1,030) $ (1,554)